MolecuLight Inc

Press Release: MolecuLight Inc Successfully Completes SOC 2 Type II Audit. The company's compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security

MolecuLight Successfully Completes SOC 2 Type II Audit - MolecuLight The company’s compliance to SOC 2 Type II demonstrates the suitability of the design and operating effectiveness of its controls relevant to security TORONTO, ON – (December 12, 2023) MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial l...

Looking for Reimbursement information on fluorescence imaging (MolecuLight Inc ) for detection of elevated bacterial burden presence, location and load? Check out Today's Wound Clinic ’s Wound Clinic “Reimbursement Library” https://www.hmpgloballearningnetwork.com/site/twc/reimbursement-z

Watch reimbursement expert Kathleen D. Schaum sharing her insights about HOPD coding and Medicare payment for the MolecuLight Inc procedure for real-time fluorescence wound imaging for bacterial presence, location, and load in wounds. This 25 minute video is suggested for wound care clinicians, coders and billers who are interested in the reimbursement pathway for the MolecuLight procedure in a HOPD setting

HOPD Coding and Medicare payment for the MolecuLight Procedure Watch reimbursement expert Kathleen D. Schaum, MS, President of Kathleen D. Schaum & Associates, Inc share her insights about HOPD coding and Medicare paymen...